CAR- T as well as cellular genetics treatments are as well costly

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and technology transfer can supply cell genetics therapies at a budget friendly cost to clients around the world.